World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma informs about GDPR and how we handle your personal information
Read more >> -
Xbrane Biopharma informerar om GDPR och personuppgiftshantering
Read more >> -
Kommuniké från årsstämman i Xbrane Biopharma
Read more >> -
Announcement from Xbrane Biopharma's annual general meeting
Read more >> -
Xbrane Biopharma och Episurf bjuder in till bolagspresentation den 29 maj i Stockholm
Read more >>
X
